Phenylketonuria Treatment; a Lifetime Diet with Very Limited Intake of Foods with Phenylalanine

Phenylketonuria Treatment
Phenylketonuria Treatment

There is no cure for phenylketonuria (PKU), but treatment can prevent intellectual disabilities and other health problems. PKU is a rare inherited disorder that causes an amino acid called phenylalanine to build up in the body. It is caused by mutations in the gene that helps make an enzyme called phenylalanine hydroxylase (PAH). This enzyme is needed to convert the amino acid phenylalanine into other substances the body needs. Without treatment, PKU can damage the brain and nervous system, which can lead to learning disabilities.

Because phenylketonuria is a genetic condition, it can't be prevented or avoided. Genetic testing is the only way to determine if people carry defective gene. Phenylketonuria does not shorten life expectancy, with or without Phenylketonuria Treatment. Newborn screening is required to detect PKU. PKU is usually identified by newborn screening. In Japan, newborn screening was started in October 1977 to detect five inborn errors of metabolism including phenylketonuria, galactosemia, histidinemia, homocystinuria, and maple syrup urine disease.

Newborn screening identifies almost all cases of phenylketonuria. It is a blood test given to newborns 24-72 hours after birth. A child's outlook is very good if she strictly follows the diet. The main Phenylketonuria Treatment Market is a low-protein diet that completely avoids high-protein foods and controls intake of many other foods, such as potatoes and cereals. The most important treatment is a diet that limits foods with phenylalanine; means the diet must be low in protein. Newborns diagnosed with the disease must use special infant formula.

Take protein substitute as prescribed and at set times each day, at least 3 to 4 times daily. Eat regular small, frequent low phenylalanine meals. The main Phenylketonuria Treatment include: A lifetime diet with very limited intake of foods with phenylalanine. People should take PKU formula for life to make sure they get enough essential proteins and nutrients that are essential for growth and general health.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more